Showing results (131-140 of 306) with videos related to

Sort By:
Pageof 31
Experimental Hematology|March 1, 1986
Recurrence of acute leukemia more than two years after allogeneic marrow graftingR Witherspoon, N Flournoy, E D Thomas, et al.
Experimental Hematology|September 1, 1981
Treatment of severe aplastic anemia using antithymocyte globulin with or without an infusion of HLA haploidentical marrowK C Doney, P L Weiden, C D Buckner, et al.
American Journal of Clinical Oncology|August 26, 1998
A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapyC H Weaver, B Zhen, L Schwartzberg, et al.
Transplantation|December 1, 1978
Pretransplant lymphocytotoxins do not predict bone marrow graft rejectionR Storb, J A Hansen, P L Weiden, et al.
Human Immunology|February 1, 1981
Marrow transplantation from donors other than HLA identical siblingsJ A Hansen, R A Clift, E M Mickelson, et al.
Experimental Hematology|November 1, 1985
Marrow transplantation for treatment of pregnancy-associated aplastic anemiaK Doney, R Storb, C D Buckner, et al.
Cancer|November 15, 1981
Bone marrow transplantation for acute myelosclerosisJ W Smith, H M Shulman, E D Thomas, et al.
Bone Marrow Transplantation|May 1, 1996
Microbial contamination of peripheral blood stem cell collectionsH Attarian, W I Bensinger, C D Buckner, et al.
Blood|January 1, 1986
The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemiaC B Thompson, J E Sanders, N Flournoy, et al.
Blood|June 15, 1991
Toxicity and immunomodulatory effects of interleukin-2 after autologous bone marrow transplantation for hematologic malignanciesC M Higuchi, J A Thompson, F B Petersen, et al.
Pageof 31